to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Although HandR Block had always been philanthropic, Henry Bloch wanted to establish a company foundation truly committed to the needs of the community as opposed to furthering corporate objectives.
An angel investor provides a succinct set of tips on how to pitch your company to investors. Key advice: project confidence and boil your pitch down to one or two sentences to establish a frawework for the audience.
Raising money by selling equity to investors is a rare activity for companies, says CommonAngels' James Geshwiler. Not many CEOs get much practice or guidance on how to do this key task. This document is a sample template for entrepreneurs to use in pitching their companies to angel investors, and covers six main areas of risk and ability to generate return for investors.
This worksheet calculates ROI via online technology called RouteTrack, which coordinates product delivery and distribution.
As vice chairman of America Online, owner of sports teams and serial entrepreneur, Ted Leonsis has accomplished enough for many lifetimes. In addition, however, he uses the leverage of his position and his entrepreneur's drive to tackle a multitude of philanthropic goals.
Entrepreneurs looking for seed capital should consider Toronto TSX Venture Exchange's Capital Pool Company (CPC) program, which allows companies to go public by merging with a CPC.
London's Alternative Investment Market (AIM) is a credible alternative for U.S. companies looking for a market listing. As with any approach to IPO, U.S. companies should research AIM's advantages and disadvantages for listing compared with U.S. stock markets.
PIPES-or Private Investment in Public Equity-as a vehicle for companies to raise capital reverses the order of public filings from IPO or secondary offering. PIPES are a worthy alternative for raising public money but should be used selectively.
Looking at ways to do a public offering, the founders of a biotech company chose a reverse merger, an alternative public offering that ultimately provided the company with access to more funding sources and higher valuation.
Terry Bruggeman shares the tale of leading his life sciences company through the decision to obtain capital. After exploring the funding options, including VC and IPO, Bruggeman and his team decide to undertake a reverse merger.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.